Sign Out
Central nervous system: Headache.
1% to 10%: Central nervous system: Drowsiness, fever, dizziness, anxiety, cold sensation.
Dermatologic: Pruritus, rash.
Gastrointestinal: Constipation, diarrhea.
Genitourinary: Gynecological disorder, urinary retention.
Hepatic: Increased ALT/AST.
Local: Injection site reaction.
Neuromuscular & skeletal: Paresthesia.
Respiratory: Hypoxia.
<1%: Anaphylaxis, angina, bronchospasm, EKG changes, extrapyramidal reactions, grand mal seizures, hypokalemia, tachycardia, vascular occlusive events.
Postmarketing and/or case reports: Angioedema, cardiopulmonary arrest, dystonic reactions, flushing, hiccups, hypersensitivity reactions, hypotension, laryngeal edema, laryngospasm, oculogyric crisis, shock, shortness of breath, stridor, urticaria.
View ADR Monitoring Form
